Page last updated: 2024-08-18

xanthenes and Parkinson Disease

xanthenes has been researched along with Parkinson Disease in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kondo, K; Matsumura, K; Okuda, Y; Takahashi, Y; Yamamoto, T	1
Degkwitz, R	1

Reviews

1 review(s) available for xanthenes and Parkinson Disease

Article	Year
[l-dopa treatment of Parkinson's syndrome and mechanism of action of neuroleptics]. Medizinische Klinik, 1969, Aug-15, Volume: 64, Issue:33 Topics: Acetylcholine; Basal Ganglia; Butyrophenones; Chorea; Dihydroxyphenylalanine; Dopamine; Extrapyramidal Tracts; Humans; Methyldopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Parkinson Disease, Secondary; Phenothiazines; Reserpine; Tranquilizing Agents; Xanthenes	1969

Article

Year

[l-dopa treatment of Parkinson's syndrome and mechanism of action of neuroleptics].

Medizinische Klinik, 1969, Aug-15, Volume: 64, Issue:33

Topics: Acetylcholine; Basal Ganglia; Butyrophenones; Chorea; Dihydroxyphenylalanine; Dopamine; Extrapyramidal Tracts; Humans; Methyldopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Parkinson Disease, Secondary; Phenothiazines; Reserpine; Tranquilizing Agents; Xanthenes

1969

Other Studies

1 other study(ies) available for xanthenes and Parkinson Disease

Article	Year
[Treatment of Parkinsonism with Tremarial (SJ-1977)]. No to shinkei = Brain and nerve, 1967, Volume: 19, Issue:7 Topics: Adolescent; Adult; Atropine; Female; Humans; Male; Middle Aged; Parasympatholytics; Parkinson Disease; Parkinson Disease, Secondary; Phenothiazines; Piperidines; Schizophrenia; Xanthenes	1967